Potential Therapies

This section looks at a selection of the therapies being tested at present. We encourage a person to be cautious about any treatment or technique that has not yet been proven to be safe or effective in the treatment of MS. Your neurologist, MS nurse or other health care professionals will be able to give you more information to enable you to make a decision about your treatment options.

• Chronic cerebro-spinal venous insufficiency

Chronic cerebrospinal venous insufficiency (CCSVI) is a condition thought to be caused by constrictions of large veins in the neck and chest.
CCSVI Information Sheet (.pdf, 131KB)

• Fampridine (also know as Fampyra)

Fampridine is an oral tablet that is being developed to help improve walking ability.
Fampridine Information Sheet (.pdf, 101KB)

• Savitex

Sativex is the world's first prescription medicine derived from the cannabis plant
Savitex Information Sheet (.pdf, 122KB)

• Cladribine

Cladribine is an oral disease modifying therapy being developed for relapsing-remitting MS.
Cladribine latest news and information

• Fingolimod (also known as Gilenya)

Gilenya (Fingolimod) is a new type of therapy that can be taken orally rather than by injection or infusion.
Fingolimod latest news and information
Frequently Asked Questions (.pdf, 106KB)

• LDN (Low Dose Naltrexone) 

LDN Information Sheet (.pdf, 100KB)

Check out Disease Modifying Drugs>>>